Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Symptoms and Side Effects in Cancer Survivors
Deadline: 31 December 2020
New Therapeutic Advances in Rare Tumors
Deadline: 31 December 2020
Intestinal Cancers and Surgery in Inflammatory Bowel Diseases
Deadline: 31 December 2020
Small Cell Lung Cancer: A New Era Is Beginning?
Deadline: 31 December 2020
Advances in Plasma Oncology toward Clinical Translation
Deadline: 1 January 2021
Gene Expression and Molecular Profiling of Human Cancer Stem Cells
Deadline: 15 January 2021
Schwannomas – So-Called Benign Nervous System Tumors
Deadline: 31 January 2021
Targeted Cancer Therapy
Deadline: 31 January 2021
Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer
Deadline: 31 January 2021
Cancer-Associated Fibroblast
Deadline: 31 January 2021
Combination Therapies in Cancers
Deadline: 31 January 2021
B Cell Lymphoma
Deadline: 31 January 2021
of 269

